Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.9B | 3.0B | 3.3B | 3.2B |
Cost of revenue | 1.0B | 1.0B | 1.0B | 1.0B |
Gross profit | 1.8B | 2.0B | 2.2B | 2.2B |
Operating expense | ||||
Research & development | 15.2M | 9.5M | 11.9M | 12.3M |
Selling general and admin | 679.8M | 98.5M | 1.1B | 437.4M |
Other operating expenses | 56.5M | 58.8M | 67.6M | 65.2M |
Operating income | 1.3B | 1.4B | 1.5B | 1.5B |
Non operating interest income | ||||
Income | 34.6M | 31.6M | 35.1M | 44.1M |
Expense | 29.5M | 31.0M | 34.3M | 35.6M |
Other income expense | — | — | — | — |
Pretax income | 1.4B | 1.4B | 1.7B | 1.7B |
Tax provision | 240.0M | 251.9M | 246.5M | 268.0M |
Net income | 1.1B | 1.2B | 1.5B | 1.4B |
Basic EPS | 0.1 | — | — | — |
Diluted EPS | 0.1 | — | — | — |
Basic average shares | 14.4B | — | — | — |
Diluted average shares | 14.4B | — | — | — |
EBITDA | 1.4B | 1.5B | 1.8B | 1.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | 4.2M | 19.9M | 23.2M | 14.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |